Multiple Manufacturers

AGGRASTAT

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Multiple Manufacturers

Aggrastat HCPCS:

J3246

HCPCS Code Descriptor:

Injection, tirofiban hcl, 0.25 mg

Category:

J Code

Aggrastat NDCs:

55150-0429-01, 25208-0002-02, 55150-0430-01, 25208-0001-04, 25208-0002-03, 25208-0002-01, 14789-0102-05, 14789-0102-10, 25208-0902-01, 25208-0902-02

Primary Type:

Anti-platelet

Generic/Specialty Status:

Multi-Source

Package Type:

Multiple

Route of Administration:

Intravenous

Aggrastat CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have identified listing errors with the following NDCs:

25208-0902-01, 14789-0102-10, 25208-0001-04, 25208-0902-02, 14789-0102-05, 25208-0002-01, 25208-0002-03

About Aggrastat:

AGGRASTAT is a medication manufactured by multiple manufacturers and aligned to the J Code: J3246. AGGRASTAT is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J3246 Added Date:

January 1, 2005

J3246 Effective Date:

January 1, 2023

J3246 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Aggrastat billing and coding information.
Our team did not identify a source for Aggrastat patient assistance information. Please reach out to our team if you feel that this is a mistake.
AGGRASTAT prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for AGGRASTAT. Please check back in a few weeks.